Redhill Biopharma Ltd.-SP ADRRDHL
13F holders, Q4 2024 (December 31)11holders +1
1new positions
2sold out
$6.20avg. 13F price*
At the end of Q4 2024, 11 institutions reported holding Redhill Biopharma Ltd.-SP ADR (RDHL) in their 13F filings, up 1 from Q3 2024. 1 opened new positions and 2 sold out. The largest holders were GAMMA Investing LLC ($32K), UBS Group AG ($27K) and Federation des caisses Desjardins du Quebec ($21K).
- Company
- Redhill Biopharma Ltd.-SP ADR
- CUSIP
- 757468301
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $32K |
| Exits | 2 | $61 |
All 13F filers, Q3 2024 → Q4 2024: 11,706 shares bought and 611 shares sold, net +11,095 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 11 holders
| GAMMA Investing LLC | 0.00% | New | 5,089 | $32K |
| UBS Group AG | 0.00% | Add +145466.7% | 4,367 | $27K |
| Federation des caisses Desjardins du Quebec | 0.00% | Reduce -15.1% | 3,388 | $21K |
| Morgan Stanley | 0.00% | Add +1129.4% | 2,213 | $14K |
| Rhumbline Advisers | 0.00% | Add +22.4% | 1,198 | $7K |
| Osaic Holdings, Inc. | 0.00% | No change | 396 | $2K |
| Group One Trading LLC | 0.00% | No change | 22 | $135 |
| Bank of America Corp. | 0.00% | No change | 2 | $12 |
| Vermillion Wealth Management, Inc. | 0.00% | — | 2 | $12 |
| SBI Securities Co., Ltd. | 0.00% | — | 2 | $12 |
| Royal Bank of Canada | 0.00% | Add +33.3% | 4 | $0 |
"% of holder's portfolio" is RDHL's weight in each manager's 13F, not the share of Redhill Biopharma Ltd.-SP ADR the manager owns.